Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1364700
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1364700
Clinical Oncology Next Generation Sequencing Market, By Workflow Type, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 269 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Clinical Oncology Next Generation Sequencing Market size was valued at USD 388.4 Million in 2022, expanding at a CAGR of 16.5% from 2023 to 2030.
Next-generation sequencing (NGS), also known as massively parallel sequencing, is a powerful method for capturing a vast quantity of genomic information about a tumor. The majority of NGS technologies rely on synthesis-based sequencing. NGS has recently been used in clinical oncology to advance individualized cancer treatment. NGS is utilized to find familial cancer mutation carriers, identify novel and rare cancer mutations, and offer molecular rationale for effective targeted therapy. With targeted therapies becoming the new standard of care in oncology, NGS-driven companion diagnostics are generally expected to influence therapy selection to enhance patient outcomes.
Clinical Oncology Next Generation Sequencing Market- Market Dynamics
The rising prevalence of cancer is expected to drive the growth of the Clinical Oncology Next Generation Sequencing market.
As the prevalence of cancer rises, there is more need to better understand the disease and discover novel medicines. Next-generation sequencing (NGS) assays are quickly becoming the preferred option in the treatment of advanced cancer patients. NGS assays use high-throughput DNA sequencing technology to sequence the complete genome, the full exome, or certain gene exons (targeted panels). In the United States in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer. For every 100,000 people, 403 new cancer cases were reported and 144 people died of cancer. 2020 is the latest year for which incidence data are available, according to Centers for Disease Control and Prevention. Furthermore, Next Generation Sequencing opens the entrance to new oncological research discoveries, which may uncover new cancer progression pathways and processes. It provides growth opportunities for the market. However, the high cost of initial investment required for NGS technology and infrastructure can restrict market growth,
Clinical Oncology Next Generation Sequencing Market- Key Insights
- As per the analysis shared by our research analyst, the global Clinical Oncology Next Generation Sequencing market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2023-2030)
- The Clinical Oncology Next Generation Sequencing market is predicted to expand rapidly as a result of growing technological advancements and increased research spending.
- Based on Workflow segmentation, NGS Sequencing was predicted to show maximum market share in the year 2022
- Based on Technology segmentation, Targeted Sequencing, and resequencing were the leading type in 2022
- Based on Application segmentation, Screening was the leading type in 2022
- Based on End-User segmentation, Screening was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Clinical Oncology Next Generation Sequencing Market- Segmentation Analysis:
The Global Clinical Oncology Next Generation Sequencing Market is segmented on the basis of Workflow Type, Application, Technology, End-User, and Region.
The market is divided into three categories based on Workflow: NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis. The NGS Sequencing segment dominates the market. NGS refers to a class of current sequencing technologies that enable significantly faster and less expensive DNA and RNA sequencing than older approaches. These technologies have the ability to sequence millions to billions of DNA molecules at the same time.
The market is divided into three categories based on Technology: Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing and resequencing. Targeted Sequencing and resequencing segment dominates the market growth. Rather than sequencing the entire genome, targeted sequencing focuses on certain genes or regions of interest that have been linked to disease or are suspected to be linked to disease. The sequencing of previously sequenced DNA is referred to as resequencing. The purpose is to find variants, particularly in areas of interest.
The market is divided into two categories based on application: Screening, Companion Diagnostics, and other diagnostics. The Screening sector dominates the market and is likely to maintain its dominance during the forecast period. Next-generation sequencing (NGS) of tumor and germline DNA is foundational for precision oncology, with rapidly expanding diagnostic, prognostic, and therapeutic implications. The use of NGS in oncology diagnostic and screening techniques has resulted in significant market expansion. The need for NGS panels, equipment, and related services has increased dramatically.
The market is divided into three categories based on End-User: Hospitals, Clinics, and Laboratories. Laboratories dominate the market. Many diagnostic laboratories have implemented NGS platforms to provide tumor genomic profiling, assisting doctors in identifying actionable mutations and tailoring medicines accordingly.
Clinical Oncology Next Generation Sequencing Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Clinical Oncology next-generation Sequencing market, due to increasing R&D investment, and the Rising Burden of Cancer. The increased incidence of cancer in North America needs novel diagnostic and treatment options. The United States invests much in medical and biotechnology research.
Both the public and commercial sectors invest billions of dollars in R&D each year, fueling improvements and the acceptance of new technology. New data from the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation indicate that research and experimental development (R&D) performed in the United States totaled USD 717.0 billion in 2020. Europe is expected to be the second-largest market for Clinical Oncology Generation Sequencing, due to increasing penetration of new medical technologies.
Clinical Oncology Next Generation Sequencing Market- Competitive Landscape:
The market for next-generation sequencing (NGS) technologies has expanded substantially. Decision-makers in health care require factual knowledge of market growth and future trends in order to design suitable strategies and regulations, yet little is known about the nature and magnitude of these patterns. Companies frequently collaborate or merge to boost their position. Major firms are expanding their presence into emerging countries in Asia, Latin America, and Africa, where there is a growing demand for modern medical technologies. Also, a number of startups bring fresh technology or approaches to the table, which may offer faster sequencing, higher accuracy, or lower prices. For example, On April 12, 2022, Thermo Fisher Scientific recently launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in one day.
Recent Developments:
In December 2021, Roche nowadays announced the launch of the AVENIO Edge System, a core component of Roche's strategy to advance sequencing technologies. Built on best-in-class foundational capabilities to deliver a fully automated, integrated sequencing solution. Roche is committed to developing diagnostic solutions with the goal of providing the healthcare community with faster and more accurate medical information to predict risk and detect disease.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET KEY PLAYERS
- Illumina, Inc.
- Thermo Fisher Scientific
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies
- Myriad Genetics
- Foundation Medicine
- Paradigm Diagnostics
- Partek, Inc.
- Pacific Bioscience
- Qiagen N.V.
- Beijing Genomics Institute (BGI)
- Perkin Elmer
- Oxford Nanopore Technologies Ltd.
- Caris Life Sciences
- Eurofins Scientific S.E.
GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW TYPE
- NGS Pre-Sequencing
- NGS Sequencing
- NGS Data Analysis
GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION
- Screening
- Sporadic Cancer
- Inherited Cancer
- Companion Diagnostics
- Other Diagnostics
GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY END-USER
- Hospitals
- Clinics
- Laboratories
GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1748
Table of Contents
1. Clinical Oncology Next Generation Sequencing Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Clinical Oncology Next Generation Sequencing Market Snippet by Workflow Type
- 2.1.2. Clinical Oncology Next Generation Sequencing Market Snippet by Technology
- 2.1.3. Clinical Oncology Next Generation Sequencing Market Snippet by Application
- 2.1.4. Clinical Oncology Next Generation Sequencing Market Snippet by End-User
- 2.1.5. Clinical Oncology Next Generation Sequencing Market Snippet by Country
- 2.1.6. Clinical Oncology Next Generation Sequencing Market Snippet by Region
- 2.2. Competitive Insights
3. Clinical Oncology Next Generation Sequencing Key Market Trends
- 3.1. Clinical Oncology Next Generation Sequencing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Clinical Oncology Next Generation Sequencing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Clinical Oncology Next Generation Sequencing Market Opportunities
- 3.4. Clinical Oncology Next Generation Sequencing Market Future Trends
4. Clinical Oncology Next Generation Sequencing Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Clinical Oncology Next Generation Sequencing Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Clinical Oncology Next Generation Sequencing Market Landscape
- 6.1. Clinical Oncology Next Generation Sequencing Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Clinical Oncology Next Generation Sequencing Market - By Workflow Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Workflow Type, 2022 & 2030 (%)
- 7.1.2. NGS Pre-Sequencing
- 7.1.3. NGS Sequencing
- 7.1.4. NGS Data Analysis
8. Clinical Oncology Next Generation Sequencing Market - By Technology
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
- 8.1.2. Whole Genome Sequencing
- 8.1.3. Whole Exome Sequencing
- 8.1.4. Targeted Sequencing & Resequencing
9. Clinical Oncology Next Generation Sequencing Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 9.1.2. Screening
- 9.1.2.1. Sporadic Cancer
- 9.1.2.2. Inherited Cancer
- 9.1.3. Companion Diagnostics
- 9.1.4. Other Diagnostics
10. Clinical Oncology Next Generation Sequencing Market - By End-User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
- 10.1.2. Hospitals
- 10.1.3. Clinics
- 10.1.4. Laboratories
11. Clinical Oncology Next Generation Sequencing Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Clinical Oncology Next Generation Sequencing Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. Illumina, Inc.
- 12.2.2. Thermo Fisher Scientific
- 12.2.3. F. Hoffmann-La Roche Ltd.
- 12.2.4. Agilent Technologies
- 12.2.5. Myriad Genetics
- 12.2.6. Foundation Medicine
- 12.2.7. Paradigm Diagnostics
- 12.2.8. Partek, Inc.
- 12.2.9. Pacific Bioscience
- 12.2.10. Qiagen N.V.
- 12.2.11. Beijing Genomics Institute (BGI)
- 12.2.12. Perkin Elmer
- 12.2.13. Oxford Nanopore Technologies Ltd.
- 12.2.14. Caris Life Sciences
- 12.2.15. Eurofins Scientific S.E.
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
Product Code: ANV1748
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Clinical Oncology Next Generation Sequencing Market: Workflow Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Workflow Type
- TABLE Global Clinical Oncology Next Generation Sequencing Market, by Workflow Type 2018-2030 (USD Million)
- TABLE Clinical Oncology Next Generation Sequencing Market: Technology Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Technology
- TABLE Global Clinical Oncology Next Generation Sequencing Market, by Technology 2018-2030 (USD Million)
- TABLE Clinical Oncology Next Generation Sequencing Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Clinical Oncology Next Generation Sequencing Market, by Application 2018-2030 (USD Million)
- TABLE Clinical Oncology Next Generation Sequencing Market: End-User Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End-User
- TABLE Global Clinical Oncology Next Generation Sequencing Market, by End-User 2018-2030 (USD Million)
- TABLE Clinical Oncology Next Generation Sequencing Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Clinical Oncology Next Generation Sequencing Market, by Region 2018-2030 (USD Million)
- TABLE North America Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
- TABLE North America Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
- TABLE North America Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
- TABLE North America Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
- TABLE North America Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
- TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
- TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
- TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
- TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
- TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
- TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
- TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
- TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
- TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
- TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.